Cargando…
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
Epigenetic alterations play an important role in tumor progression of diffuse large B-cell lymphoma (DLBCL). However, the biological relevance of epigenetic gene mutations on tumor microenvironment remains to be determined. The core set of genes relating to histone methylation (KMT2D, KMT2C, EZH2),...
Autores principales: | Huang, Yao-Hui, Cai, Kun, Xu, Peng-Peng, Wang, Li, Huang, Chuan-Xin, Fang, Ying, Cheng, Shu, Sun, Xiao-Jian, Liu, Feng, Huang, Jin-Yan, Ji, Meng-Meng, Zhao, Wei-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801454/ https://www.ncbi.nlm.nih.gov/pubmed/33431788 http://dx.doi.org/10.1038/s41392-020-00437-8 |
Ejemplares similares
-
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023) -
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
por: Garcia-Carpizo, Veronica, et al.
Publicado: (2018) -
Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors
por: Crawford, McKenna C., et al.
Publicado: (2023) -
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300
por: Williams, Lynn M., et al.
Publicado: (2020) -
CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein–Taybi syndrome
por: Wincent, Josephine, et al.
Publicado: (2015)